Filing Details
- Accession Number:
- 0001209191-20-024494
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-15 16:57:36
- Reporting Period:
- 2020-04-13
- Accepted Time:
- 2020-04-15 16:57:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1736295 | E Maria Pasquale | 1801 Augustine Cut-Off Wilmington DE 19803 | Evp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-04-13 | 127 | $65.36 | 23,864 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-04-13 | 965 | $85.68 | 22,899 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-04-14 | 17,827 | $65.36 | 40,726 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-04-14 | 17,827 | $90.00 | 22,899 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Incentive Stock Option (right to buy) | Disposition | 2020-04-13 | 127 | $0.00 | 127 | $65.36 |
Common Stock | Non Qualified Stock Option (right to buy) | Disposition | 2020-04-14 | 17,827 | $0.00 | 17,827 | $65.36 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
4,078 | 2028-04-09 | No | 4 | M | Direct | |
17,250 | 2028-04-09 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- This includes an aggregate of 20,648 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.
- Beginning April 9, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.